Cargando…
Terminal deletion of chromosome 13 in a fetus with normal NIPT: The added value of invasive prenatal diagnosis in the NIPT era
In the age of noninvasive prenatal testing, there is still an important role for invasive prenatal diagnosis, even for chromosomes 13, 18, and 21.
Autores principales: | Vervecken, Evy, Blaumeiser, Bettina, Vanderheyden, Tina, Hauspy, Jan, Janssens, Katrien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455455/ https://www.ncbi.nlm.nih.gov/pubmed/32884775 http://dx.doi.org/10.1002/ccr3.2889 |
Ejemplares similares
-
Detection of 21q11.2‐q22.11 deletions in a fetus by NIPT
por: Zheng, Yunyun, et al.
Publicado: (2019) -
Non-invasive prenatal testing (NIPT): is routinization problematic?
por: Rehmann-Sutter, Christoph, et al.
Publicado: (2023) -
Systematic evaluation of NIPT aneuploidy detection software tools with clinically validated NIPT samples
por: Paluoja, Priit, et al.
Publicado: (2021) -
Application value of NIPT for uncommon fetal chromosomal abnormalities
por: Yin, Lianli, et al.
Publicado: (2020) -
NIPT and the concerns regarding ‘routinisation’
por: Horn, Ruth
Publicado: (2022)